UPDATE 1-Novartis makes history with U.S. launch of 'biosimilar' drug
September 03, 2015 at 03:37 AM EDT
ZURICH/LONDON, Sept 3 (Reuters) - Novartis kicked off a new era in U.S. medicine on Thursday with the launch of the first "biosimilar" copy of a biotechnology drug approved in the United States, following a green light from a U.S. appeals court.